Silk Road Medical Inc financial data

Location
Sunnyvale, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q2 2024 - 07 Aug 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 894% % -3.5%
Quick Ratio 105% % 29%
Debt-to-equity 73% % -7.5%
Return On Equity -37% % 5.8%
Return On Assets -22% % 2.6%
Operating Margin -31% % 3.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 40,632,143 shares 4.6%
Common Stock, Shares, Outstanding 40,612,481 shares 4.6%
Common Stock, Value, Issued $41,000 USD 5.1%
Weighted Average Number of Shares Outstanding, Basic 39,620,888 shares 2.2%
Weighted Average Number of Shares Outstanding, Diluted 39,620,888 shares 2.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $191,431,000 USD 18%
Research and Development Expense $42,654,000 USD 9.7%
Operating Income (Loss) $60,174,000 USD -13%
Net Income (Loss) Attributable to Parent $56,538,000 USD -6.9%
Earnings Per Share, Basic -1 USD/shares -2.9%
Earnings Per Share, Diluted -1 USD/shares -2.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $22,639,000 USD -20%
Cash, Cash Equivalents, and Short-term Investments $184,327,000 USD -8.8%
Accounts Receivable, after Allowance for Credit Loss, Current $26,252,000 USD 22%
Inventory, Net $29,682,000 USD 56%
Assets, Current $241,021,000 USD 3.2%
Property, Plant and Equipment, Net $8,381,000 USD -3%
Operating Lease, Right-of-Use Asset $5,920,000 USD -16%
Other Assets, Noncurrent $6,227,000 USD -15%
Assets $269,807,000 USD 2.4%
Accounts Payable, Current $3,693,000 USD -31%
Accrued Liabilities, Current $27,879,000 USD 49%
Contract with Customer, Liability, Current $270,000 USD 23%
Liabilities, Current $31,572,000 USD 31%
Operating Lease, Liability, Noncurrent $6,561,000 USD -18%
Other Liabilities, Noncurrent $7,404,000 USD -14%
Liabilities $115,123,000 USD 6.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax $122,000 USD 63%
Retained Earnings (Accumulated Deficit) $430,194,000 USD -15%
Stockholders' Equity Attributable to Parent $154,684,000 USD -0.53%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $154,684,000 USD -0.53%
Liabilities and Equity $269,807,000 USD 2.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $15,322,000 USD -26%
Net Cash Provided by (Used in) Investing Activities $17,741,000 USD 191%
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 40,612,481 shares 4.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $2,419,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $22,639,000 USD -20%
Interest Paid, Excluding Capitalized Interest, Operating Activities $1,440,000 USD 1.6%
Operating Lease, Liability $8,321,000 USD -14%
Payments to Acquire Property, Plant, and Equipment $388,000 USD 35%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $56,329,000 USD -5.9%
Lessee, Operating Lease, Liability, to be Paid $9,833,000 USD -17%
Operating Lease, Liability, Current $1,760,000 USD 5.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,255,000 USD 13%
Lessee, Operating Lease, Liability, to be Paid, Year One $2,130,000 USD 115%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,512,000 USD -30%
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,068,000 USD -2.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Additional Paid in Capital $584,959,000 USD 10%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Share-based Payment Arrangement, Expense $41,256,000 USD 25%
Interest Expense $6,912,000 USD 0.89%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%